Role of Nanobiotechnology in Drug Discovery, Development and Molecular Diagnostic by Dash, Deepak Kumar et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
125,000 140M
TOP 1%154
5,000
1Chapter
Role of Nanobiotechnology in 
Drug Discovery, Development and 
Molecular Diagnostic
Deepak Kumar Dash, Rajni Kant Panik, Anil Kumar Sahu  
and Vaibhav Tripathi
Abstract
Nano-biotechnology has already tested its magnitude in a number of sections 
of existence science and biotechnology field. It is no longer hyperbole to say that in 
future, nano-scale method would in reality take the associated science area to the 
subsequent level. Since, there are technical hurdles present; despite the fact that 
scientists are giving their great to overcome such problems. Applications of nano-
biotechnology have already been discussed in this chapter. Future potential are 
really associated with innovative amendment of such applications. Despite of some 
impedance, this technology presents giant hope in the future. It performs most 
important position in distinct sorts of biomedical application such as shipping of 
drug, gene therapy, biosensors, biomarkers and molecular imaging. It additionally 
leads to innovations in this field. The fundamental lookup goal of this discipline 
would be the innovation of early analysis approach and cure with target-specific 
remedy therapy. Although there would possibly be some safety worries with admire 
to the in vivo use of nanoparticles, research are in region to decide the nature and 
extent of adverse events.
Keywords: nanobiotechnology, drug discovery, drug design, nanoparticle, 
biosensors
1. Introduction
The effective treatment for disease requires the improvement of diagnostic 
method, development of optimized drug loaded formulation and incorporation of 
optimized formulation in to suitable delivery system in terms of role of nanotech-
nology in drug discovery and development.
There has been challenging task for researchers to increase analytical capacity 
with improved data quality, consuming less sample volume for storage and screening 
of cell and tissue library at molecular level. In current scenario the innovative format 
of nanotechnology offers advancement in the technology, overcoming the initial 
challenges of unreliable data, consuming high sample and various other issues [1].
Pharmaceutical industries are continually facing a challenge to find better 
drug discovery technologies because of availability of various competitive other 
medicinal market. This industry requires discovering and developing new medi-
cines for the effective treatment of wide range of diseases likely to grow regulatory 
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challenges, costing revolution and various other barriers. Recently, all pharma-
ceutical companies giving importance to common processes including cloning and 
expressing human receptors and enzymes for discovering innovative drugs, that 
allow high throughput, automated screening and the application of combinatorial 
chemistries. Presently, the drug discovery industry should have massive amounts 
of data about life’s molecular components in the area of genomics and proteomics 
revolution [2].
The Pharmaceutical and biotechnology firms have spent billions of dollars on 
novel technologies in order to improve productivity, accelerate the drug discovery 
and development processes and sustain market share.
Nanotechnology refers to development of innovative research and technology at 
the atomic, molecular and macromolecular level with controlled manipulation, and 
the study of structures and devices are done in the 1 to 100 nanometers range. The 
conclusive remark at this scale, Nanoparticle take on beneficial novel properties and 
functions like small size, surface tailorability, improved solubility, and multifunc-
tionality as compared to seen in the bulk scale. This nanofield may open many new 
avenues of research for biologists. The novel nanotechnology using nano-materials 
can interact with complex biological organ consuming low level of biomolecules.
The development and design of multifunctional nanoparticle offers new oppor-
tunity for interdisciplinary researchers that can target, diagnose and treat diseases 
such as cancer. Within the field of discovery and development of nanomaterials, 
nanotechnology focuses to improve diagnostic methods, improved drug loaded 
delivery system for the effective and enhanced therapy. Now a days, the scientific 
community is paying attention on the physical, chemical and biological properties 
of nano-sized materials so that development of new applications can be done in 
order to improve human health.
Earlier the nanotechnological concepts have been discussed in 1959 by physi-
cist Richard Feynman during his talk “There’s Plenty of Room at the Bottom,” 
describing manipulation of atom is a key to possible different method of syn-
thesis. In 1974, Norio Taniguchi used the term “nanotechnology.” The scanning 
tunneling microscope was invented in the year 1981, ensures the clear visibility 
of individual atoms and bonds. Initially the term nanotechnology was used in 
designing nanoscale devices studying about carbon nanotube [3]. The National 
Nanotechnology Initiative (NNI) defines nanotechnology as research and develop-
ment of nanosized delivery system with novel functional properties. Subsequently 
manipulation of atoms could be possible to create efficient nanomaterials with 
characterized invitro and invivo parameters. Thus the inherent nanoscale functional 
properties to the biological tissues, proves that nanotechnology could be feasible 
for the application to the life sciences successfully. With growing research in the 
field of nanotechnology, large number of nanotechnologies using nanomaterials 
has been studied, but there is no study about safety and toxicity. For this purpose 
in vitro diagnostic use of nanotechnology without any safety risks to people and in 
vivo characterization of nanoparticles, ranging smaller size <50 nm in size, were 
studied. The smaller size of nanoparticle concerns over the entry and localization 
of the particles in to the cells, but there are still many unanswered questions related 
to huge diversity of materials used and its wide range in the sizes of nanoparticles, 
these effects will vary a lot. It has been conceived by many researchers that particu-
lar sizes might turn out to have toxic effects and consequently further investigation 
are required. The FDA approval is mandatory for clinically approval the applica-
tions of nanotechnology and substantial regulatory problems in the nanotechnol-
ogy-based product. Consequently the term “nanobiotechnology,” has come in to 
existence as a unique fusion of biotechnology and nanotechnology [4]. This article 
will provide an integrated overview of application of nanobiotechnology based 
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molecular diagnostics, drug discovery, and drug delivery in the development of 
nanomedicine with the relationships.
2. Nanobiotechnology
The word “Nanobiotechnology” is a combined study of “The Nanotechnology” 
including design, development and application of nanomaterials & devices and 
“The Biotechnology” including the various function of biological site like micro-
organisms [4]. The field of nanobiotechnology will grow in the development 
and discovery of drug in upcoming scenario at exponential rate, Where atom or 
molecule level devices can be constructed by incorporation of drug in to suitable 
biocompatible delivery system. Hence nanobiotechnology can help various aspects 
of biological problem with the help of nanotechnology and information technology. 
This technology has capacity to build bridge among different branches of sci-
ences providing newer challenges and opening new door in the field of research & 
diagnostics, education in the near future [5]. Relation between nanobiotechnology, 
bionanotechnology, and nanobiology are the terms referring to the intersection 
of nanotechnology and biology. Nanobiotechnology includes recent advances in 
nanotechnology to improve biotechnology, and bionanotechnology, which aims to 
have advantage of natural/biomimetic approaches to create devices with nanosize 
range [6].
This article will focus on the principal trends and the implications of nanobio-
technology in drug discovery, development and molecular diagnostic.
3. Advantages of nanobiotechnology
Nanoformulation based on oral and topical drug delivery in biotechnology can 
stimulate molecular imaging for brain tissue engineering and drug delivery through 
blood brain barrier, Improvement of CNS directed neuroprotection or regenera-
tion, drug uptake assistance, showing fewer side-effects compared to conventional 
molecules, more active therapeutically in treating brain tumors, Successful biodis-
tribution, High bioavailability, DNA and RNA molecules provide high affinity and 
binding on specific target site, devoid of enzymatic degradation enriches lymphatic 
Figure 1. 
Advantages of nanobiotechnology.
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transport, development of biosensors, nontoxic and biodegradable nature, 
enhancement of the potency of anticancer drugs, in vivo and in vitro biomedical 
research and accomplishment of easy Drug targeting (Figure 1) [7–13].
4. Nanobiotechnology in drug discovery and development
The application of nanobiotechnology has an impact on diagnostics and drug 
delivery. Currently, researchers are starting to use nanotechnology in the field of 
drug discovery and development. Nanocrystals (QDs) and other nanoparticles 
(gold colloids, magnetic nanoparticles, nanobarcodes, nanobodies, dendrimers, 
fullerenes, and nanoshells) have unique advantages for the development of drug 
and its discovery i.e. QDs and magnetic nanoparticles are being used for barcod-
ing of specific analytes which are key components of the bio-barcode assay, can be 
future alternative to the protein chain reaction [1].
The term “Nanomolecular diagnostics” is the use of nanobiotechnology at 
molecular level to diagnose and treat chronic diseases”, extending the limits of 
molecular diagnostics to the nanoscale. The nanomolecular diagnostic field can meet 
the rigorous demands of the clinical laboratory and can be cost-effectiveness [6].
Nanoparticles have emerged as promising nanoplatforms for efficient diagnos-
tics and therapeutics possessing characteristic properties at the nanometric scale. 
The feasible immobilization of specific ligands on the surface of biological site have 
become ideal candidates for molecularly sensitive detection, molecular imaging, 
and novel carriers for targeted drug and gene delivery, targeted photothermal ther-
apy [6]. The nanoparticle in the form of nano-vesicle surrounded by a membrane or 
a layer holds convenient surface i.e. spherical, cylindrical, plate-like for molecular 
assembly of inorganic or polymeric materials and drug. The size and size distribu-
tion of nanoparticle becoming extremely critical and plays very significant role 
for penetration through a pore structure of a cellular membrane. The Biomarkers 
for occupying their distinguished color requires efficient fluorescent probes which 
depends upon the narrow distribution of average particle sizes. These narrow sizes 
particles emit a very wide range of wavelengths. The multifunctional nano particles 
core with several luminescent layers like magnetic nanoparticles can detect and 
manipulate the particles. Thus the Nanoparticles provides combine platform of 
biotechnology, nanotechnology and information technology facilitating molecular, 
biochemical and biological processes, e.g. genetics and pharmacogenomics.
The surface morphology of nanoparticles can be redesigned to reach at their 
target like blood brain barrier and dermal tight junctions more efficiently, overcom-
ing the efficacy issues of drug on the physiological barriers. In case of malignant 
tumors Nanoparticles with leaky vasculature structure may penetrate the lesion. 
Nanoparticles may contain natural and synthetic polymer for coating an inorganic 
core of superparamagnetic materials. Some examples of nanoparticles as contrast 
agents in magnetic resonance for molecular diagnosis are given here [5].
4.1 Gold nanoparticles
Gold nanoparticles are the most typically used nanomaterial in diagnostics; they 
have many different uses as properly. They may be extensively utilized as a con-
necting factor and to construct biosensors to hit upon ailment DNA. Rather than a 
fluorescent molecule, a gold nanoparticle can be attached to an antibody and other 
molecules, consisting of DNA, can be brought to the nanoparticle to supply bar 
codes. The gold particles are very chemically reactive and make excellent catalysts 
at nanometer scale. Recently, gold nanostructures have found a very important 
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role in a wide variety of applications, including bio-imaging, drug delivery, toxic 
gas detection, biosensors and to demonstrate multiphoton absorption-precipitated 
luminescence (mail) [14].
4.2 The quantum dots for drug discovery
Quantum dots (QDs) are regarded as a unique class of fluorescent labels, with 
unique optical properties such as high brightness and long-term colloidal and 
optical stability; these are suitable for optical imaging, drug delivery and optical 
tracking, fluorescence immunoassay and other medicinal applications. The unique 
optical property of QDs allows one to investigate the real-time dynamic events in 
living cells and such events include interaction between intracellular proteins, the 
mechanisms of intracellular signal transmission and cell growth. Some benefits and 
downsides have been investigated more suitable optical residences compared with 
natural dyes like incredible imaging outcomes using organic dyes, absorption of 
numerous drug molecules for an extended time frame [15].
4.3 Conjugates of nanoparticles and DNA protein
Conjugation Nanoparticle-DNA protein hold great promise in biomedical appli-
cations. Many Diverse strategies have been developed to conjugate nanoparticles 
and DNA proteins to assemble and purify nanoparticle-protein link. First, stable 
and biocompatible nanoparticles are synthesized. Conjugation of the nanoparticle 
to the DNA protein is then achieved via two different approaches that do not 
require heavy chemical modifications or cloning, cysteine-gold covalent bonding, 
or electrostatic attachment of the nanoparticle to charged groups of the protein. 
Co-functionalization of the nanoparticle with PEG thiols is recommended to help 
protein folding. Finally, structural characterization is performed with circular 
dichroism, as this spectroscopy technique has proven to be effective at examin-
ing protein secondary structure in nanoparticle-protein conjugates. In general, 
functionalization of NPs with proteins such as antibodies can be achieved by direct 
chemical covalent conjugation or electrostatic interactions. The Semi-artificial 
conjugates of nucleic acids and proteins by both covalent coupling chemistry, or else 
through noncovalent biomolecular recognition systems, which include receptor-
ligands of complementary nucleic acids for immunological detection assays [15].
4.4 Nanochips
The Nano Chip System by utilizing electronically enhanced hybridization of 
complementary DNA strands, integrates advanced microelectronics and molecular 
biology into a platform technology with broad commercial applications in the fields 
of genomic diagnostics and has achieved 100% accuracy in the detection of nanopar-
ticle. This technique helps in investigating DNA sequences or the pairing of separated 
strands of DNA with complementary DNA strands of the acknowledged collection 
that act as probes. Currently, DNA chips is known as DNA microarray assays that 
employs the energy of a digital contemporary that separates DNA probes to unique 
web sites at the array based on charge and size, then test sample (blood) can be 
analyzed for identifying DNA sequences via hybridization with these probes [16].
4.5 Microfluidics (lab-on-a chip)
Microfluidics is the modern science of fluids on the nanometer scale. The 
nanodiagnostics involve microfluidic or “lab on a chip” structures, in which the 
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combination of numerous approaches of DNA analysis is mixed on an unmarried 
chip composed of an unmarried glass and silicon substrate. Academically, it is a 
subdiscipline of fluid mechanics, as the fundamental equations describing the 
physics of fluids at larger length scales are identical to the equations underlying 
microfluidics. In general, the microfluidic biosensor platforms offer numerous 
advantages compared with other traditional methods such as ultracentrifugation, 
electrophoresis, nuclear magnetic resonance, chromatographic approaches, etc. for 
detection of bio-species molecules. This device have capable of measuring aqueous 
reagent and DNA-containing answers, mixing the solutions together, amplifying 
or digesting the DNA to shape discrete merchandise, Destiny possibilities for the 
utility of nanotechnology in healthcare and for the development of personalized 
remedy seem like amazing [17].
5. Nanobiotechnology in designing of drug delivery system
Among the new technologies, nano-biotechnology has evoked considerable 
interest for application in the pharmaceutical industry. Important applications of 
nano-biotechnology are in the areas of drug discovery, drug development, and 
drug delivery, and these are collectively referred to as nano-pharmaceuticals. 
Nano-biotechnology, particularly the use of nanoparticles, has made significant 
contributions to drug discovery and development [18]. In addition to the use of 
nano-biotechnology for drug discovery, some drugs are being developed from nano-
materials. Well-known examples of these are dendrimers, fullerenes, and nano-bodies. 
At present time increasing the use of nano-biotechnology in many pharmaceutical and 
biotechnology industries is anticipated. In case of drug development from formulate to 
appropriate dose to administer with optimal delivery systems, nanotechnology is being 
utilized at all the stages. Nano-biotechnology applications are also involving in diag-
nosis of diseases. In future it may be possible to computers are connected with nano-
biotechnology systems and provide the appropriate and complete knowledge about 
complete model or an individual cell. This virtual representation might be helpful for 
researcher or scientist to develop novel drugs with high rate of accuracy and precision 
without conducting any experiment in living organisms.
The major challenges in front of drug delivery scientists are poor solubility, high 
molecular size and low bioavailability for clinical candidates. Other challenges in 
this field are pediatric and geriatric drug administration, protein and peptide drug 
delivery etc. Today’s major demand in drug delivery field is to develop ideal, safe 
and effective, non-invasive drug delivery methods.
Nano-biotechnology sector play a significant role to overcome the above 
drug delivery problems. It provides the following solution related drug delivery 
problems: (a) With the help of this technology particle size of drugs is reduced 
in nanometer size range, it enhance the surface area and ultimately improve rate 
of dissolution, (b) Nano-meter size range of drug also useful to improve their 
solubility, (c) With the help of this technology scientists trying to develop non-
invasive routes of drug administration method which can eliminates the use of 
injectable drugs, (d) developed nanoparticle formulations has better alternate for 
non-stable and lower shelf lives formulations, (e) nanotechnology based formu-
lations improved the solubility of poorly soluble drug and enhance absorption 
capability, improved bioavailability and release rate of large molecules, reduced 
the optimum dose and enhance the safety margin by reducing the side effects, (f) 
Nano-biotechnology principles help in developing of Sustain and controlled release 
formulations with better patient compliance [19].
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6. Nano-biotechnology in molecular diagnostic
Nano technology has gained enormous popularity in recent past decades. In lay 
man language nano technology is defined as the use of least possible input to get 
maximum possible output. Nano word is used in terms of size. This technology 
is considered as wonderful amalgamation of physics and chemistry. When this 
technique is applied with biology, it brings about a new field termed as Nano-
biotechnology; where biochemical processes are modified to get far better results 
than that of simple bio technological procedures.
As far as the medical field is concerned, the harness of nano- biotechnology for 
diagnostic purpose is successfully obtained (Figure 2). It assists to develop more 
sensitive diagnostic kits than that of existing one. Such instruments are suitable to 
probe the bodily problems at cellular pores and receptor level. Moreover, it is due 
to tiny sized diagnostic materials the degree of toxic and adverse effects have been 
markedly reduced. New dimensions of diagnostic tools have been explored with the 
aid of this cutting edge technique. Several modifications are still under develop-
mental phase.
6.1 Nano-particles used in the diagnosis
Gold nano-particles are also termed as metallic particles. These are produced 
from gold salts of either organic, aqueous or both origins. A suitable stabilizer 
is used to get stable particles with good ligand binding capacity. Usable size of 
particles is ranging between 3 and 100 nm. The major application is due to their 
electronic, optical, and thermal properties [20].
Magnetic nano particles are formulated from magnetic materials like Fe3O4, 
Fe2O3, and many other ferrites. Nanoparticles can be incorporated with bio- marker 
moieties so that they can be utilized to investigate various biomolecules and help 
in different processes like separation and purification. The involvement of surface 
coating materials is significant to ascertain the size and kinetics of these particles. 
That’s why the nature of coating materials should be examined before use [21].
Quantum dots are semiconductor nano-crystals that are easy to synthesize 
and have characteristic properties that are between those of bulk semiconductor 
and discrete molecules. Their diameter ranges from 2 to 10 nm. Their fluorescent 
property relies on size of the quantum dot [22].
Carbon nano tubes are composed of graphite. On the basis of number of graphite, 
these nano tubes are categorized into two classes- tubes with only one layer of graphite 
Figure 2. 
Application of nanobiotechnology for molecular diagnosis.
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are known as mono walled carbon nano tubes on the other hand, tubes consist of mul-
tiple layers of graphite are termed as multi walled carbon nano tubes. The main advan-
tage of such tubes is that they can conduct high electricity with less or no heating effect. 
This happens because of scattering free traveling of electrons throughout the tube [23].
Liposomes are spherical vesicles where an aqueous core is surrounded by a 
phospholipid bilayer and cholesterol. The phospholipid consists of a hydrophilic 
head and two oil-loving tails. The phospholipid that is predominantly used is 
phosphatidyl choline [24].
Dendrimers are the emerging and well defined polymeric architectures that 
are known for their large, complex and well defined structures, versatility in drug 
delivery and high functionality whose properties resemble with biomolecules. 
These nanostructured macromolecules have potential abilities to entrap and to 
conjugate the high molecular weight hydrophilic/hydrophobic drugs by host-guest 
interactions and covalent bonding (prodrug approach) around an inner core 
respectively. They have different Features like size, shape, branching length, and 
their surface functionality vary over the design of nanoparticles. For example, 
Polyamidoamine are usually used dendrimers [25].
Nano bio sensors are applied to investigate biochemical changes with the aid of elec-
tronic, optical or magnetic technology. Furthermore, detection and/or quantification of 
bio molecules like specific base pairs or proteins are also possible. Majority of biosensors 
work on the principle of key and lock theory or affinity based mechanism; where immo-
bilized tool attaches to target molecule/analyte being sensed in this phenomenon, any 
change at a localized surface can be examined rather than detecting target in solution. 
This variation can be sensed by using one of the following methods; viral biosensors, 
light sensitive biosensors, resonant cantilever and quartz crystal microbalance [26].
6.2 Nanotechnology used in diagnosis
6.2.1 Nanotechnology-based biochips/microarrays
A nano material can be perfectly examined by using same sized probe. This 
hypothesis is applied in molecular diagnosis with the help of biochips or microar-
rays. This is because the cell organelles/biological moieties exist in nano size and the 
biochips also falls under in almost similar tiny sized scale. Nano fluidic arrays and 
protein nano biochips are the examples of nanotechnology based biochips. These chips 
are capable to isolate and analyze living cell molecules such as genetic material DNA. In 
future this technique will certainly bring about revived investigation tool for cancer. 
Nano-fluidic technology is expected to have broad applications in systems biology, per-
sonalized medicine, pathogen detection, drug development, and clinical research [27].
6.2.2 Nanotechnology-based cytogenetic
Cytogenetic has been used mainly to elaborate spatial arrangement of the chro-
mosome and screening of abnormalities related to disease. The use of fluorescent in 
situ hybridization (FISH) is now reaching its limit. Molecular cyto-genetics is now 
enhanced by use of biomedical nanotechnology, e.g., use of atomic force micros-
copy (AFM) and quantum dot (QD) FISH [28].
6.2.3 Nano-proteomic-based diagnostics
A comprehensive study including identification, characterization and analysis of 
a series of bio protein at a specified time is known as proteomics. Proteomics help to 
recognize the variations which are associated with various pathological conditions. 
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These variations are identified on the basis of spatio-temporal position of protein 
molecules. A small change in molecular level can bring about such variations as a 
consequence proteome may be altered; which are further quantified for clinical 
diagnosis. Gel- based and gel- free are the common proteomics techniques, which 
work on separation, observation, analysis and marking the altered proteome [29].
6.2.4 Nanoparticle-based nucleic acid diagnostics
Screening of pathogenic microorganism on the basis of genomic arrangement 
has become relevant in current clinical determination. It has been well established 
central dogma of life that each and every living organism has a peculiar set of DNA, 
which has been transferred from one generation to next without any sort of altera-
tion; this can also be said to be the individualization by nature. In clinical diagnosis, 
this DNA fragment may help to check the availability of the microorganism in 
the test sample. This investigation opens the door for molecular detection. This is 
carried out by using polymerase chain reaction (PCR) or hybridization techniques, 
known as amplification method and non-amplification method respectively. 
Therefore, this technique is considered to be more sensitive and precise than that of 
other techniques [30].
6.2.5 Nano-bio-sensors
Bio sensors are sophisticated probes, which are used to investigate the existence 
and/or concentration of a biological analyte, say for example bio molecule, histol-
ogy of biological material or any microorganism. Biosensors comprise of following 
parts: amplifier that detects the analyte and generate a signal along with it a signal 
transducer that converts the signal into electric impulses and a reader to record and 
investigate the signal [31].
7. Safety issues of nanoparticles
Nano-biotechnology is the fine amalgamation of multi disciplines of science. 
In pharmaceutical field, the scientists and researchers are trying to overcome the 
demerits of existing drug molecules with the aid of this wonderful technology. 
There are many expected potential benefits in bank. In spite of that safety is the 
main concern with the in- vivo application of nano engineered medicines yet.
It has been revealed that while production or use of nano medicines, such par-
ticles can easily get inside the human body and ultimately blood stream and then in 
various vital organs; where they exert unintended adverse effects, sometimes these 
effects are fetal for the user.
An in- vivo study on monkeys and rats have disclosed the aggregation of carbon 
and manganese nano materials in the olfactory bulb, which has produced severe 
pathological consequences pertaining to nervous and respiratory system.
Several animal studies have shown such sort of abnormal pathological 
disturbances.
In order to combat with this problem firstly, an efficient probe will have to 
develop for thorough assessment of risk associated with the use of nano medicine. 
Second and the most significant challenge would be to develop authentic valida-
tion protocol for testing nano medicines in animals so as to get the data of toxic 
effects in early stage of testing. A restructured, compact and integrated regulatory 
approach is much needed to look into the expected risks for delivering the promis-
ing and safe medicines [2].
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8. Regulatory perspective of nanobiotechnology
In the event that we talk about the most recent decade, nano bio-innovation 
has generated some new impedance for the research community, industry, and 
regulators. Applicable techniques have some loopholes regarding fabrication and 
processing of nano medicines, that’s why special provisions would be required to 
tide-over such complications [32]. FDA and other regulatory authorities experience 
many unavoidable consequences for the release of such products. This is due to 
non-authentic validation program in clinical trial phase [11]. A wing of researchers 
proposes sturdy contentions, revealing both positive and negative aspects pertain-
ing to the advancement of nano-materials. They suggest that vague protocol throttle 
research and product development, which represses the development and viability 
of new nano-medicines. Apart from that, a robust administrative body is made so 
as to push the business advancement by creating certainty for pharmaceutical firms 
and trust within the ultimate consumers [33]. Currently, the FDA, EMA (European 
medical agency), and other regulatory agencies examine each new nanoparticle 
individually. There is commonly an absence of benchmarks in the assessment of 
nano-medicines as a unique class of therapeutic agent [34]. Afterwards, administra-
tive corporations might imagine of a complete listing of screening and a powerful 
approbate system that enclose the complete variety of particle characterization, 
pharmacology, and toxicology troubles.
9. Future prospects
In case we consider in trendy approximately the two major capabilities of nano-
biotechnology, first is imaging and diagnostics (quantum dots) and second are pro-
teomics. In proteomics especially study and detect about nucleic acids and proteins 
[35]. Currently, the Thermal Sensitive drug delivery system has been developed for 
the treatment of cancer. In this, drug is given in the injection form, which reaches 
inside the body and converts into insoluble form and accumulates in the tumor cells 
because the temperature of the tumor cell is more than the normal cell [36]. In spite 
of the tremendous credibility of nanobiotechology, its use has been considerable due 
to its toxicity and environmental problems. Despite all this, the drug delivery, drug 
discovery, gene therapy, molecular imaging, biomarkers, and biosensors fields are 
exploring possibilities in the nanobiotechnology. Nanobiotechnology has brought a 
bright future for the clinical diagnosis and targeted drug delivery sector. Now in the 
field of diagnosis, it has become easier to detect diseased cells rapidly, due to which 
it is possible to prevent diseased cells from spreading in the body [37]. There is a 
constant development in this field right now and it is possible that some incurable 
diseases in the future will actually be cured with the resources of nanobiotechnology.
10. Conclusion
Nano-biotechnology is in its primary stage in terms of development. Due to 
continuous innovative research and abundant use, nano-biotechnology is having a 
wide impact on the fields of science and technology. Nano-biotechnology is present-
ing some unique possibilities in medicine, diagnosis and biomedical sciences. The 
innovation of nano-biotechnology in drug delivery systems has led to the introduc-
tion of something new, and with the help of this, it seems possible to treat some 
incurable diseases. Although the potential for benefits from nano-biotechnology 
is high, the prospective of nanomedicine is not fully defined. In fact, regulatory 
11
Role of Nanobiotechnology in Drug Discovery, Development and Molecular Diagnostic
DOI: http://dx.doi.org/10.5772/intechopen.92796
Author details
Deepak Kumar Dash*, Rajni Kant Panik, Anil Kumar Sahu and Vaibhav Tripathi
Royal College of Pharmacy, Chhattisgarh Swami Vivekananda Technical University, 
Bhilai, Chhattisgarh, India
*Address all correspondence to: drdeepak_dash123@yahoo.in
bodies do not have appropriate guidelines that balance its risk and safety factors. 
It would be fair to say that in future nano-biotechnology will play an excellent and 
unique role in the treatment of human diseases and the study of human physiology. 
From the research conducted in nano-biotechnology in the last few years, it can be 
inferred that in future, nano-biotechnology will become an indispensable phase of 
our daily life.
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